Event: The 2nd Annual Biopharma Innovation Conference 2017

Dates: November 29 - 30, 2017

Venue: Wyndham Bund East Shanghai, China

Weblink: www.bioinnovationforum.com

Contact: Marketing Department

Tel: +86 21 3160 2153

Email: Marketing@wbfgroup.com 

As the BioPharma industry grows in China & the Asian region. A part of our highly successful Biopharma series, the event, which attracts over 300 attendees, is the leading industry platform for Biopharma, biotech, Manufacturing Equipments, Bioscience and Analytical Equipments, Facility Design, Cold Chain, CMOs, CROs, research institutes, investors, technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China.

Covering topics ranging from latest regulations impacting to International partnering; from Biosimilar to antibody development, from Bio-manufacturing to cell culture engineering; from Cutting edge technology & solutions to best Practice case studies; from business strategy, investment to innovation.

This is probably the most important event in the year on biopharma in terms of participants. It cannot be missed.

With over 40 speakers and estimation to bring over 300 Biopharma professionals, the key congress topics will cover:  

• New investment and outlook in china biopharma industry
• Achieving Maximum Efficiency and Productivity in Bio-manufacturing
• Facility Innovations In design, technology and flexibility
• Advancements on scale-up, production, purification, expression technologies, quality control
• Regulatory perspectives on biosimilar development, licensing and registration
• Overcome hurdles unique to biosimilar development
• Analytical and statistical :Methodologies to meet high standards of biosimilarity
• Innovative approaches and optimization in early cell line development
• Advancement in antibody development

On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Biopharma industry in Asia.